In the mouse gastritis model, Gc-ME administration ameliorated stomach ulcers and reduced the expression of inflammatory genes (COX-2, IL-1β, IL6, and iNOS) and the phosphorylation of Src and IκBα. The gene discussed is NOS2; the disease is gastritis.